Sexual dysfunction associated with prostate cancer treatment in Japanese men: a qualitative research

• Published in: Supportive care in cancer 2022-04, Vol.30 (4), p.3201-3213
• Main Authors: Hayashi, Saeko, Oishi, Fumiko, Sato, Kazuki, Fukuda, Hiromi, Ando, Shoko
• Format: Article
• Language: English
• Subjects: Analysis; Androgen Antagonists - adverse effects; Brachytherapy - adverse effects; Cancer surgery; Cancer therapies; Care and treatment; Content analysis; Endocrine therapy; Humans; Japan; Male; Medicine; Medicine & Public Health; Mens health; Nursing; Nursing Research; Oncology; Original; Original Article; Pain Medicine; Prostate cancer; Prostatectomy - adverse effects; Prostatic Neoplasms - surgery; Qualitative Research; Quality of Life; Radiation therapy; Radiotherapy; Rehabilitation Medicine; Reproducibility of Results; Sexual disorders; Urological surgery
• ISSN: 0941-4355; 1433-7339
• DOI: 10.1007/s00520-021-06728-2

Purpose We investigated the experiences of Japanese men with sexual dysfunction associated with various prostate cancer treatments. Methods We included 38 Japanese men who underwent the following initial treatments for prostate cancer: radical prostatectomy ( n  = 10), external beam radiotherapy ( n  = 12), brachytherapy ( n  = 5), and androgen deprivation therapy ( n  = 11). Semi-structured interviews were conducted regarding sexual dysfunction associated with prostate cancer treatment. Data were analyzed using a content analysis method. To obtain a unique experience for each treatment, we confirmed and organized the treatment method from which the code that constituted each category was derived. The category reliability was calculated based on Scott’s formula for the matching rate of the classification by three qualitative researchers. The criterion for good reliability was set at 70%. Results Japanese men with sexual dysfunction associated with prostate cancer treatments experienced the following: a desire to maintain sexual function and conflict in decision-making concerning the initial treatment for prostate cancer; a loss of values related to sexual dysfunction; an uncertainty regarding the consequences of sexual dysfunction; a sense of calm with fewer adverse effects of sexual dysfunction at the early treatment stage; an effort to accept sexual dysfunction; and management of their changed body at the later treatment stages. The concordance rates for the categories were 70% and 78%. Additionally, there were glimpses of experiences common to all treatments and trends in treatment-specific experiences. Conclusion It is necessary to provide care based on the experience of Japanese men with sexual dysfunction after prostate cancer treatment.